Actively Recruiting

Phase Not Applicable
Age: 50Years - 99Years
All Genders
NCT05849064

Concussion Treatment in Older Adults

Led by University of Pittsburgh · Updated on 2026-03-05

50

Participants Needed

1

Research Sites

146 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.

CONDITIONS

Official Title

Concussion Treatment in Older Adults

Who Can Participate

Age: 50Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 50 years of age or older
  • Diagnosed concussion within the last 4 days to 12 months
  • Must be recruited at their initial concussion appointment
  • Ability to read and write to complete study assessments and testing
Not Eligible

You will not qualify if you...

  • Diagnosed major psychiatric disorders other than depression or anxiety (e.g., schizophrenia)
  • Diagnosed with moderate to severe brain injury or past brain surgery or malformations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15203

Actively Recruiting

Loading map...

Research Team

A

Anthony Kontos, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here